CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The growth of end-use industries
4.1.2. Rising incidence of chronic diseases
4.1.3. Technological advancements in cell-based research instruments
4.1.4. Availability of funding for cell-based research
4.2. Market Restraints & Challenges
4.2.1. Complexities related to antibody and reagent development
4.2.2. The high cost of cell signalling systems
4.3. Market Opportunities
4.3.1. The emergence of microfluidics in cell biology research
4.3.2. Emerging markets
CHAPTER 5. GLOBAL CELL SIGNALING MARKET – BY PRODUCT
5.1. Introduction
5.2. Consumables
5.2.1. Antibodies
5.2.2. Reagents
5.2.3. Assay Kits
5.2.4. Other Consumables
5.3. Instruments
CHAPTER 6. GLOBAL CELL SIGNALING MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. Western blotting
6.3. Elisa
6.4. Immunohistochemistry
6.5. Flow cytometry
6.6. Microscopy
6.7. Mass spectrometry
6.8. Other technologies
CHAPTER 7. GLOBAL CELL SIGNALING MARKET - BY SIGNALING TYPE
7.1. Introduction
7.2. Juxtacrine signalling
7.3. Autocrine signalling
7.4. Paracrine signalling
7.5. Endocrine signalling
7.6. Other signalling types
CHAPTER 8. GLOBAL CELL SIGNALING MARKET - BY PATHWAY
8.1. Introduction
8.2. AMPK signalling pathway
8.3. ErbB/HER signalling pathway
8.4. Hedgehog signalling pathway
8.5. JAK/STAT signalling pathway
8.6. Notch signalling pathway
8.7. NF-KB signalling pathway
8.8. AKT signalling pathway
8.9. Other signalling pathways
GLOBAL 9. GLOBAL CELL SIGNALING MARKET - BY APPLICATION
9.1. Introduction
9.2. Medical applications
9.3. Research applications
9.3.1. Cancer research
9.3.2. Immunology research
9.3.3. Stem cells research
9.3.4. Other research applications
9.4. Medical applications
CHAPTER 10. GLOBAL CELL SIGNALING MARKET - BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL CELL SIGNALING MARKET - COMPANY PROFILES
11.1. Beckman Coulter Inc.
11.2. Becton, Dickinson and Company
11.3. Bio-Rad Laboratories Inc.
11.4. Bio-Techne Corporation.
11.5. Cell Signaling Technology Inc.
11.6. The Merck Group
11.7. PerkinElmer Inc.
11.8. Promega Corporation.
11.9. Ge Healthcare.
11.10. Qiagen N.V.
11.11. Thermo Fisher Scientific Inc.
11.12. Luminex Corporation
11.13. Danaher Corporation.
11.14. Euro Clone S.p.A.
11.15. Irvine Scientific Sales Company, Inc.
CHAPTER 12. GLOBAL CELL SIGNALING MARKET - COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
